252 related articles for article (PubMed ID: 24746181)
1. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression.
Grage-Griebenow E; Jerg E; Gorys A; Wicklein D; Wesch D; Freitag-Wolf S; Goebel L; Vogel I; Becker T; Ebsen M; Röcken C; Altevogt P; Schumacher U; Schäfer H; Sebens S
Mol Oncol; 2014 Jul; 8(5):982-97. PubMed ID: 24746181
[TBL] [Abstract][Full Text] [Related]
2. CD4
Goebel L; Grage-Griebenow E; Gorys A; Helm O; Genrich G; Lenk L; Wesch D; Ungefroren H; Freitag-Wolf S; Sipos B; Röcken C; Schäfer H; Sebens S
Oncoimmunology; 2015 Apr; 4(4):e1000083. PubMed ID: 26137395
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
[TBL] [Abstract][Full Text] [Related]
4. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
Helm O; Mennrich R; Petrick D; Goebel L; Freitag-Wolf S; Röder C; Kalthoff H; Röcken C; Sipos B; Kabelitz D; Schäfer H; Oberg HH; Wesch D; Sebens S
PLoS One; 2014; 9(5):e94357. PubMed ID: 24797069
[TBL] [Abstract][Full Text] [Related]
5. Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent.
Schäfer H; Geismann C; Heneweer C; Egberts JH; Korniienko O; Kiefel H; Moldenhauer G; Bachem MG; Kalthoff H; Altevogt P; Sebens S
Carcinogenesis; 2012 Jan; 33(1):84-93. PubMed ID: 22095073
[TBL] [Abstract][Full Text] [Related]
6. Monitoring and functional characterization of the lymphocytic compartment in pancreatic ductal adenocarcinoma patients.
Oberg HH; Grage-Griebenow E; Adam-Klages S; Jerg E; Peipp M; Kellner C; Petrick D; Gonnermann D; Freitag-Wolf S; Röcken C; Sebens T; Vogel I; Becker T; Ebsen M; Kabelitz D; Wesch D; Sebens S
Pancreatology; 2016; 16(6):1069-1079. PubMed ID: 27424476
[TBL] [Abstract][Full Text] [Related]
7. Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells.
Geismann C; Arlt A; Bauer I; Pfeifer M; Schirmer U; Altevogt P; Müerköster SS; Schäfer H
Int J Oncol; 2011 Jan; 38(1):257-66. PubMed ID: 21109948
[TBL] [Abstract][Full Text] [Related]
8. alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma.
Sebens Müerköster S; Kötteritzsch J; Geismann C; Gast D; Kruse ML; Altevogt P; Fölsch UR; Schäfer H
Int J Oncol; 2009 Jan; 34(1):243-53. PubMed ID: 19082495
[TBL] [Abstract][Full Text] [Related]
9. The fatal alliance of cancer and T cells: How pancreatic tumor cells gather immunosuppressive T cells.
Grage-Griebenow E; Schäfer H; Sebens S
Oncoimmunology; 2014; 3():e29382. PubMed ID: 25114835
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
Hiraoka N; Onozato K; Kosuge T; Hirohashi S
Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
[TBL] [Abstract][Full Text] [Related]
12. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.
Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H
PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664
[TBL] [Abstract][Full Text] [Related]
13. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.
Bergmann F; Wandschneider F; Sipos B; Moldenhauer G; Schniewind B; Welsch T; Schirrmacher P; Klöppel G; Altevogt P; Schäfer H; Sebens Müerköster S
Oncol Rep; 2010 Oct; 24(4):909-15. PubMed ID: 20811670
[TBL] [Abstract][Full Text] [Related]
14. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
[TBL] [Abstract][Full Text] [Related]
15. Gamma-delta T cells stimulate IL-6 production by pancreatic stellate cells in pancreatic ductal adenocarcinoma.
Seifert AM; List J; Heiduk M; Decker R; von Renesse J; Meinecke AC; Aust DE; Welsch T; Weitz J; Seifert L
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3233-3240. PubMed ID: 32865617
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC.
Wang X; Li X; Wei X; Jiang H; Lan C; Yang S; Wang H; Yang Y; Tian C; Xu Z; Zhang J; Hao J; Ren H
Signal Transduct Target Ther; 2020 Apr; 5(1):38. PubMed ID: 32300119
[TBL] [Abstract][Full Text] [Related]
17. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.
Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870
[TBL] [Abstract][Full Text] [Related]
18. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
Tsutsumi S; Morohashi S; Kudo Y; Akasaka H; Ogasawara H; Ono M; Takasugi K; Ishido K; Hakamada K; Kijima H
J Surg Oncol; 2011 Jun; 103(7):669-73. PubMed ID: 21360711
[TBL] [Abstract][Full Text] [Related]
19. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
[TBL] [Abstract][Full Text] [Related]
20. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]